Cargando…
Myelin lipid deficiency: a new key driver of Alzheimer’s disease
Autores principales: | Qiu, Shulan, Palavicini, Juan Pablo, Han, Xianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241415/ https://www.ncbi.nlm.nih.gov/pubmed/35799524 http://dx.doi.org/10.4103/1673-5374.343893 |
Ejemplares similares
-
Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment
por: Qiu, Shulan, et al.
Publicado: (2021) -
Compromised Myelin and Axonal Molecular Organization Following Adult-Onset Sulfatide Depletion
por: Dustin, Elizabeth, et al.
Publicado: (2023) -
Sulfatide Deficiency, an Early Alzheimer’s Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks
por: Palavicini, Juan Pablo, et al.
Publicado: (2022) -
Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
por: He, Sijia, et al.
Publicado: (2023) -
Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes
por: Palavicini, Juan P., et al.
Publicado: (2020)